Lastly, C-reactive protein and TIMP-1 levels were augmented AD patients, and they declined amazingly after acetylcholinesterase inhibitor therapy, which is among the limited existing treatment of AD [141]. The gene discussed is TIMP1; the disease is Alzheimer disease.